Literature DB >> 7837953

Role of exercising muscle in slow component of VO2.

D C Poole1.   

Abstract

This paper: 1) Reviews evidence for the location of the slow component of VO2 kinetics either within the exercising limbs or alternatively at some site in the rest of the body, e.g., ventilatory, cardiac or accessory muscles. 2) Presents evidence in support of both the fast and slow components (i.e., < 3 min and > 3 min from exercise onset, respectively) of the exercise VO2 response residing predominantly in the exercising muscle. For a pulmonary VO2 slow component in excess of 600 ml O2.min-1, more than 80% could be attributed to an augmented VO2 across the exercising limbs. 3) Assesses the potential for the lactate ion per se to exert a metabolic stimulatory effect in exercising muscle in the absence of the potentially confounding influences of changes in muscle temperature, H+, blood flow or O2 delivery. Within the surgically isolated, electrically stimulated canine gastrocnemius, square wave infusions that increased arterial blood [lactate] by approximately 10 mM and intramuscular [lactate] to in excess of 9 mM did not increase muscle VO2. In summary, these investigations demonstrate that the exercising muscle is the predominant site of the VO2 slow component. However, despite the close temporal association between changes in blood lactate and VO2 during intense exercise, lactate itself does not mandate an additional VO2 demand in exercising dog muscle.

Entities:  

Mesh:

Year:  1994        PMID: 7837953

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  14 in total

1.  Cardiac output and oxygen release during very high-intensity exercise performed until exhaustion.

Authors:  Ruddy Richard; Evelyne Lonsdorfer-Wolf; Stéphane Dufour; Stéphane Doutreleau; Monique Oswald-Mammosser; Véronique L Billat; Jean Lonsdorfer
Journal:  Eur J Appl Physiol       Date:  2004-07-27       Impact factor: 3.078

2.  Effect of high-intensity interval training and detraining on extra VO2 and on the VO2 slow component.

Authors:  A Marles; R Legrand; N Blondel; P Mucci; D Betbeder; F Prieur
Journal:  Eur J Appl Physiol       Date:  2007-01-13       Impact factor: 3.078

3.  Blood lactate accumulation decreases during the slow component of oxygen uptake without a decrease in muscular efficiency.

Authors:  J M O'Connell; J M Weir; B R MacIntosh
Journal:  Pflugers Arch       Date:  2017-05-26       Impact factor: 3.657

Review 4.  Oxygen uptake kinetics during exercise.

Authors:  F Xu; E C Rhodes
Journal:  Sports Med       Date:  1999-05       Impact factor: 11.136

5.  Skeletal muscle fatigue precedes the slow component of oxygen uptake kinetics during exercise in humans.

Authors:  Daniel T Cannon; Ailish C White; Melina F Andriano; Fred W Kolkhorst; Harry B Rossiter
Journal:  J Physiol       Date:  2010-12-06       Impact factor: 5.182

6.  A high blood lactate induced by heavy exercise does not affect the increase in submaximal VO2 with hyperoxia.

Authors:  F B Favier; F Prieur; O Grataloup; T Busso; J Castells; C Denis; A Geyssant; H Benoit
Journal:  Eur J Appl Physiol       Date:  2005-01-29       Impact factor: 3.078

7.  Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD.

Authors:  Pierantonio Laveneziana; Paolo Palange; Josuel Ora; Dario Martolini; Denis E O'Donnell
Journal:  Eur J Appl Physiol       Date:  2009-08-27       Impact factor: 3.078

Review 8.  Effects of prior exercise on metabolic and gas exchange responses to exercise.

Authors:  Andrew M Jones; Katrien Koppo; Mark Burnley
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

9.  Sex differences in the oxygen uptake kinetic response to heavy-intensity exercise in prepubertal children.

Authors:  Samantha G Fawkner; Neil Armstrong
Journal:  Eur J Appl Physiol       Date:  2004-08-07       Impact factor: 3.078

10.  The role of oxygen in determining phosphocreatine onset kinetics in exercising humans.

Authors:  Luke J Haseler; Casey A Kindig; Russell S Richardson; Michael C Hogan
Journal:  J Physiol       Date:  2004-05-28       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.